Shakespeare’s Juliet famously asked what’s in a name, but for at least one thought leader in the clinical trial space, names do matter. A lot. “Please don’t call them ‘virtual […]
Consumers probably aren’t the only ones complaining about the rising cost of prescription drugs—not after the U.S. Food and Drug Administration (FDA) just socked drug study sponsors with hefty price […]
The U.S. Food and Drug Administration (FDA) just issued a call to industry and other interested parties to weigh in on an important draft guidance, “E8(R1) General Considerations for Clinical Studies.”